Skip to main content
. 2023 Mar 28;118(9):1626–1637. doi: 10.14309/ajg.0000000000002269

Figure 3.

Figure 3.

Survival analysis of CD-RC. (a) Five-year overall survival (OS) of CD-RC and sporadic RC patients. (b) Five-year recurrence-free survival (RFS) of CD-RC and sporadic RC patients. (c) Five-year OS of CD-RC and sporadic RC patients by stage. (d) Five-year RFS of CD-RC and sporadic RC patients by stage. CD, Crohn's disease; RC, anorectal cancer.